Expression of Pdx-1 in human gastric metaplasia and gastric adenocarcinoma

Human Pathology

Volumn 37, Issue 9, 2006, Pages 1162-1168

  Leys, Charles M ^a   Nomura, Sachiyo ^a,c   Rudzinski, Erin ^a   Kaminishi, Michio ^c   Montgomery, Elizabeth ^d   Washington, Mary Kay ^a   Goldenring, James R ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antrum; Biomarkers; Gastric cancer; Intestinal metaplasia; Pdx 1; SPEM; TFF2

Indexed keywords

TRANSCRIPTION FACTOR PDX 1;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DUODENUM; GOBLET CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; METAPLASIA; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; STOMACH ANTRUM; STOMACH CANCER; STOMACH FUNDUS; TISSUE MICROARRAY;

ADENOCARCINOMA; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; MALE; METAPLASIA; PRECANCEROUS CONDITIONS; STOMACH NEOPLASMS; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL;

EID: 33747835620     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.04.011     Document Type: Article

References (24)

1. Smith V.C., and Genta R.M. Role of Helicobacter pylori gastritis in gastric atrophy, intestinal metaplasia and gastric neoplasia. Microsc Res Tech 48 (2000) 313-320
2. Spechler S.J., and Goyal R.K. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology 110 (1996) 614-621
3. Correa P. A human model of gastric carcinogenesis. Cancer Res 48 (1988) 3554-3560
4. Filipe M.I., Munoz N., Matko I., et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 57 (1994) 324-329
5. Hattori T., Helpap B., and Gedigk P. The morphology and cell kinetics of pseudopyloric glands. Virchows Arch B Cell Pathol Incl Mol Pathol 39 (1982) 31-40
6. Schmidt P.H., Lee J.R., Joshi V., et al. Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. Lab Invest 79 (1999) 639-646
7. Yamaguchi H., Goldenring J.R., Kaminishi M., and Lee J.R. Association of spasmolytic polypeptide expressing metaplasia (SPEM) with carcinogen administration and oxyntic atrophy in rats. Lab Invest 82 (2002) 1045-1052
8. Yamaguchi H., Goldenring J.R., Kaminishi M., and Lee J.R. Identification of spasmolytic polypeptide expressing metaplasia (SPEM) in remnant gastric cancer and surveillance postgastrectomy biopsies. Dig Dis Sci 47 (2001) 573-578
9. Halldorsdottir A.M., Sigurdardottir M., Jonasson J.G., et al. Spasmolytic polypeptide expressing metaplasia (SPEM) associated with gastric cancer in Iceland. Dig Dis Sci 48 (2003) 431-441
10. Nomura S., Baxter S., Yamaguchi T., et al. Relationship of spasmolytic polypeptide expressing metaplasia (SPEM) to pre-neoplasia in H. felis-infected mice. Gastroenterology 127 (2004) 582-594
11. Nomura S., Yamaguchi H., Wang T.C., Lee J.R., and Goldenring J.R. Alterations in gastric mucosal lineages induced by acute oxyntic atrophy in wild type and gastrin deficient mice. Am J Physiol 288 (2004) G362-G375
12. Houghton J., Stoicov C., Nomura S., et al. Gastric cancer originating from bone marrow derived cells. Science 306 (2004) 1568-1571
13. Wang T.C., Dangler C.A., Chen D., et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 118 (2000) 36-47
14. Fox J.G., Li X., Cahill R.J., et al. Hypertrophic gastropathy in Helicobacter felis-infected wild type C57BL/6 mice and p53 hemizygous transgenic mice. Gastroenterology 110 (1996) 155-166
15. Wang T.C., Goldenring J.R., Dangler C., et al. Mice lacking secretory phospholipase A2 show altered apoptosis and differentiation with Helicobacter felis infection. Gastroenterology 114 (1998) 675-689
16. Mutoh H., Hakamata Y., Sato K., et al. Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice. Biochem Biophys Res Commun 294 (2002) 470-479
17. Silberg D.G., Sullivan J., Kang E., et al. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology 122 (2002) 689-696
18. Nomura S., Settle S.H., Leys C., et al. Evidence for repatterning of the gastric fundic epithelium associated with Menetrier's disease and TGFα overexpression. Gastroenterology 128 (2005) 1292-1305
19. Larsson L.I., Madsen O.D., Serup P., Jonsson J., and Edlund H. Pancreatic-duodenal homeobox 1-role in gastric endocrine patterning. Mech Dev 60 (1996) 175-184
20. Offield M.F., Jetton T.L., Labosky P.A., et al. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122 (1996) 983-995
21. Sakai H., Eishi Y., Li X.L., et al. PDX1 homeobox protein expression in pseudopyloric glands and gastric carcinomas. Gut 53 (2004) 323-330
22. Elia G., Chinery R., Hanby A.M., Poulsom R., and Wright N.A. The production and characterization of a new monoclonal antibody to the trefoil peptide human spasmolytic polypeptide. Histochem J 26 (1994) 644-647
23. Taupin D., Pedersen J., Familari M., Cook G., Yeomans N., and Giraud A.S. Augmented intestinal trefoil factor (TFF3) and loss of pS2 (TFF1) expression precedes metaplastic differentiation of gastric epithelium. Lab Invest 81 (2001) 397-408
24. Buettner M., Dimmler A., Magener A., et al. Gastric PDX-1 expression in pancreatic metaplasia and endocrine cell hyperplasia in atrophic corpus gastritis. Mod Pathol 17 (2004) 56-61